Dare Bioscience (DARE) News Today $2.04 -0.07 (-3.32%) As of 03:47 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DARE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Dare Bioscience (NASDAQ:DARE) Upgraded at Maxim GroupSeptember 7, 2025 | americanbankingnews.comMaxim Group Upgrades Daré Bioscience (DARE)September 6, 2025 | msn.comDare Bioscience upgraded to Buy from Hold at MaximSeptember 4, 2025 | msn.comDaré Bioscience Engages Market with New PresentationSeptember 3, 2025 | msn.comDaré Bioscience, Inc. (NASDAQ:DARE) Q2 2025 Earnings Call TranscriptAugust 16, 2025 | msn.comDaré Bioscience Announces Q2 2025 Financial ResultsAugust 15, 2025 | msn.comDaré Bioscience, Inc.: Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 15, 2025 | finanznachrichten.deDaré Bioscience targets Q4 2025 launch for DARE to PLAY Sildenafil cream while advancing dual-path strategyAugust 14, 2025 | msn.comDaré Bioscience, Inc. (DARE) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comDaré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 14, 2025 | globenewswire.comA Preview Of Dare Bioscience's EarningsAugust 13, 2025 | benzinga.comDaré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025August 7, 2025 | globenewswire.comDaré Bioscience, Inc.: Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY Sildenafil CreamJuly 29, 2025 | finanznachrichten.deDaré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil CreamJuly 29, 2025 | finance.yahoo.comDaré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil CreamJuly 29, 2025 | globenewswire.comUPDATE - Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the BarJuly 21, 2025 | globenewswire.comDaré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the BarJuly 21, 2025 | finance.yahoo.comDaré Bioscience, Inc.: Positive Interim Phase 3 Results Highlight Potential of Ovaprene, Novel Hormone-Free ContraceptiveJuly 15, 2025 | finanznachrichten.deDare Bioscience Analyst Ratings and Price Targets | NASDAQ:DARE | BenzingaJuly 15, 2025 | benzinga.comDaré Bioscience Shares Soar on Data From Phase 3 Contraceptive StudyJuly 15, 2025 | marketwatch.comCrude Oil Moves Lower; Daré Bioscience Shares JumpJuly 14, 2025 | benzinga.comPositive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free ContraceptiveJuly 14, 2025 | globenewswire.comDaré Bioscience, Inc.: Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for ...July 12, 2025 | finanznachrichten.deDaré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic DisordersJuly 11, 2025 | globenewswire.comDARE Daré Bioscience, Inc. - Seeking AlphaJuly 3, 2025 | seekingalpha.comDaré Bioscience Announces Adjournment of Annual Meeting of StockholdersJune 12, 2025 | globenewswire.comDaré Bioscience, Inc.: Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company UpdateMay 17, 2025 | finanznachrichten.deQ1 2025 Dare Bioscience Inc Earnings CallMay 16, 2025 | finance.yahoo.comDaré Bioscience outlines $4.5B hormone therapy market entry and expects Q4 2025 revenue as dual path strategy expandsMay 14, 2025 | seekingalpha.comDaré Bioscience, Inc. (DARE) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comDaré Bioscience Reports First Quarter 2025 Financial Results and Provides Company UpdateMay 13, 2025 | globenewswire.comDare Bioscience's Earnings OutlookMay 12, 2025 | benzinga.comDrug Development Is Slowing Down After Cuts at the FDAApril 17, 2025 | msn.comDare Bioscience to present on expanded business strategy at Jones ConferenceApril 8, 2025 | markets.businessinsider.comMaxim Group Keeps Their Hold Rating on Daré Bioscience (DARE)April 5, 2025 | markets.businessinsider.comQ4 2024 Dare Bioscience Inc Earnings CallApril 1, 2025 | finance.yahoo.comDaré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comDare Bioscience expects to start recording revenue, cash flow in Q425April 1, 2025 | markets.businessinsider.comDaré Bioscience targets Q4 2025 for Sildenafil Cream launch via 503B compoundingMarch 31, 2025 | msn.comDaré Bioscience, Inc. (DARE) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comDaré Bioscience Reports Full Year 2024 Financial Results and Provides Company UpdateMarch 31, 2025 | globenewswire.comDare Bioscience Q4 2024 Earnings PreviewMarch 30, 2025 | msn.comA Look Ahead: Dare Bioscience's Earnings ForecastMarch 28, 2025 | benzinga.comDaré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025March 24, 2025 | globenewswire.comDaré Bioscience and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive ImplantFebruary 20, 2025 | finance.yahoo.comDare Bioscience risks Nasdaq delisting over market valueFebruary 14, 2025 | msn.comDare Bioscience secures additional NIAID funding for HPV treatmentFebruary 6, 2025 | msn.comDaré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV DevelopmentFebruary 6, 2025 | globenewswire.comDaré Bioscience to Participate in the Women’s Health Series at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 9, 2025 | markets.businessinsider.comDaré Bioscience to Participate in the Women's Health Series at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 9, 2025 | globenewswire.com Get Dare Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DARE Media Mentions By Week DARE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DARE News Sentiment▼1.450.94▲Average Medical News Sentiment DARE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DARE Articles This Week▼22▲DARE Articles Average Week Get the Latest News and Ratings for DARE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Dare Bioscience and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Biomea Fusion News Pliant Therapeutics News Equillium News InflaRx News VistaGen Therapeutics News TScan Therapeutics News Oncolytics Biotech News HilleVax News Coya Therapeutics News Surrozen News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DARE) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dare Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dare Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
